A detailed history of Lgt Fund Management CO Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Lgt Fund Management CO Ltd. holds 133,355 shares of ABT stock, worth $17.4 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares
133,355
Previous 114,355 16.61%
Holding current value
$17.4 Million
Previous $13 Million 15.69%
% of portfolio
1.37%
Previous 1.37%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

BUY
$111.93 - $119.39 $2.13 Million - $2.27 Million
19,000 Added 16.61%
133,355 $15.1 Million
Q3 2024

Nov 13, 2024

BUY
$100.07 - $118.13 $3.24 Million - $3.82 Million
32,355 Added 39.46%
114,355 $13 Million
Q2 2024

Aug 07, 2024

BUY
$100.73 - $112.44 $8.26 Million - $9.22 Million
82,000 New
82,000 $8.52 Million
Q1 2022

May 11, 2022

SELL
$114.02 - $139.04 $410,472 - $500,544
-3,600 Closed
0 $0
Q4 2021

May 03, 2022

BUY
$115.53 - $141.46 $415,908 - $509,256
3,600 New
3,600 $507,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $229B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Lgt Fund Management CO Ltd. Portfolio

Follow Lgt Fund Management CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Fund Management CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Lgt Fund Management CO Ltd. with notifications on news.